BARTON HOUSE GROUP PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: F84008 | LONDON, N16 9JT
Showing results 451-500 of 593
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Salicylic acid | 22 | 242 | £80 | +74.0% ▲ |
| Diphtheria | 22 | 22 | £167 | -67.0% ▼ |
| 22 | 32 | £324 | +8.8% ▲ | |
| 22 | 48 | £705 | +68.3% ▲ | |
| 22 | 360 | £247 | -71.5% ▼ | |
| Olmesartan medoxomil | 21 | 1,764 | £76 | -69.5% ▼ |
| Simple | 21 | 4,200 | £32 | +82.9% ▲ |
| Riluzole | 21 | 2,152 | £5.4K | +102.4% ▲ |
| Erythromycin | 21 | 2,092 | £638 | -39.4% ▼ |
| Itraconazole | 21 | 820 | £380 | +56.5% ▲ |
| Mebendazole | 21 | 164 | £21 | +83.4% ▲ |
| Carbomer 940/980 | 21 | 730 | £143 | -86.2% ▼ |
| Glycopyrronium bromide | 21 | 179 | £297 | -11.9% ▼ |
| Midazolam hydrochloride | 21 | 176 | £107 | -48.7% ▼ |
| 21 | 1,860 | £670 | +8.6% ▲ | |
| Sennosides | 20 | 6,850 | £131 | -35.2% ▼ |
| Hydralazine hydrochloride | 20 | 280 | £17 | -52.6% ▼ |
| Glycopyrronium bromide | 20 | 1,020 | £889 | -46.3% ▼ |
| Mycophenolate mofetil | 20 | 1,624 | £191 | -50.6% ▼ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 20 | 13.2K | £205 | -12.7% ▼ |
| Clindamycin phosphate | 20 | 840 | £159 | +21.6% ▲ |
| 20 | 1,600 | £232 | +12.6% ▲ | |
| 20 | 2,030 | £421 | +111.0% ▲ | |
| Rotigotine | 19 | 700 | £2.2K | -29.6% ▼ |
| Valaciclovir | 19 | 688 | £871 | +35.2% ▲ |
| Powder amino acid formula (0913107) | 19 | 36.4K | £2.3K | -42.5% ▼ |
| Prednisolone acetate | 19 | 175 | £61 | +4.2% ▲ |
| Brinzolamide and timolol | 19 | 260 | £352 | -49.7% ▼ |
| Fludroxycortide | 19 | 59 | £1.4K | +80.2% ▲ |
| 19 | 363 | £5.2K | +176.7% ▲ | |
| 19 | 95 | £261 | +162.2% ▲ | |
| 19 | 2,700 | £330 | -15.1% ▼ | |
| Perampanel | 18 | 1,008 | £4.8K | -16.9% ▼ |
| Fosfomycin trometamol | 18 | 28 | £130 | -36.7% ▼ |
| Glucose | 18 | 2,430 | £216 | -65.4% ▼ |
| Betamethasone sodium phosphate | 18 | 830 | £110 | +46.4% ▲ |
| Mupirocin | 18 | 66 | £89 | +53.3% ▲ |
| Aciclovir | 18 | 88 | £81 | +46.0% ▲ |
| 18 | 66 | £881 | +77.4% ▲ | |
| 18 | 200 | £546 | -62.4% ▼ | |
| 18 | 116 | £195 | +9.1% ▲ | |
| Methyldopa | 17 | 2,464 | £525 | -0.2% vs avg |
| Atomoxetine hydrochloride | 17 | 588 | £1.2K | -49.7% ▼ |
| Pizotifen malate | 17 | 2,688 | £111 | -79.4% ▼ |
| Tizanidine hydrochloride | 17 | 2,376 | £101 | -35.8% ▼ |
| Ketoprofen | 17 | 1,650 | £71 | -52.6% ▼ |
| Pimecrolimus | 17 | 640 | £389 | +0.4% vs avg |
| 17 | 1,600 | £527 | +22.7% ▲ | |
| Prucalopride | 16 | 616 | £322 | -58.9% ▼ |
| Cinacalcet hydrochloride | 16 | 364 | £147 | -31.0% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.